Mobile health intervention for managing hypertension in ICH survivors
Official title: MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors
Run by The University of Hong Kong · NCT05830305 · Data updated 2026-11-12
This study is testing a mobile health program to see if it helps people who have survived a brain bleed manage their high blood pressure better than regular doctor visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT05830305 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have been diagnosed with primary intracerebral hemorrhage and have a modified Rankin Scale score of 4 or less upon discharge.
✕Probably not a fit
Patients who may not benefit include those with severe comorbid conditions, significant cognitive impairments, or those unable to access or use the WeRISE app for monitoring.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial evaluates the effectiveness and safety of a mobile health intervention aimed at managing hypertension in survivors of intracerebral hemorrhage (ICH). A total of 140 participants will be divided into two groups: one receiving the mobile health intervention, which includes daily blood pressure monitoring through the WeRISE app and regular follow-up calls for medication adjustments, and the other receiving standard care from their physicians. The study will track participants for 26 weeks to assess the control of hypertension at specified intervals. The intervention emphasizes education on hypertension management and lifestyle modifications, such as the DASH diet.
Why it matters
Potential benefit: If successful, this intervention could significantly improve blood pressure control in ICH survivors, potentially reducing the risk of further complications.
How similar studies have gone: Other studies have shown promise in using mobile health interventions for chronic disease management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary ICH Diagnosis * Age ≥ 18 years * Discharge Modified Rankin Scale of ≤4 Exclusion Criteria: * Expected life expectancy of \<1 year * Patient or caregiver does not have access to WeRISE App. * Patient or caregiver does not know how to use WeRISE App . * Inability to perform home BP monitoring * Inability to participate in follow-up activity * Contraindication for intensive and rapid lowering of blood pressure (Known \>70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure * Bleeding tendency (Platelet count \< 75 x 10\^9/L; Known coagulation disorder) * Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula \<30 ml/min/1.73m2) * Severe liver impairment (Child-Pugh C cirrhosis) * Known contraindication or allergy to two or more anti-hypertensive classes
Where it's running
-
Queen Mary Hospital
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Kay Cheong Teo, MBBS
- Email: kcteo@hku.hk
- Phone: (852)22553749
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clevidipine to control high blood pressure after acute intracerebral hemorrhage
This trial will test whether IV clevidipine helps adults with acute intracerebral hemorrhage reach and keep their target systolic blood pressure within 60 minutes better than other IV blood-pressure medicines.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.